Skip to Main Content
Yonghui Chen
Close
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Sunitinib or Sorafenib as Neoadjuvant Therapy May not Improve the Survival Outcomes of Renal Cell Carcinoma with Tumor Thrombus

Subject Area:
Further Areas
Wen Cai, Jiwei Huang, Yichu Yuan, Xiaoyi Hu, Mingyang Li, Wen Kong, Jin Zhang, Jianming Guo, Yonghui Chen, Yiran Huang
Journal: Urologia Internationalis
Urol Int (2018) 101 (4): 391–399.
https://doi.org/10.1159/000492723
Published Online: 05 September 2018
View article titled, Sunitinib or Sorafenib as Neoadjuvant Therapy May not Improve the Survival Outcomes of Renal Cell Carcinoma with Tumor Thrombus
Open the PDF for Sunitinib or Sorafenib as Neoadjuvant Therapy May not Improve the Survival Outcomes of Renal Cell Carcinoma with Tumor Thrombus in another window
Journal Articles

Primitive Neuroectodermal Tumor of the Kidney: A Single-Institute Series of Six Patients from China

Subject Area:
Further Areas
Jiwei Huang, Jin Zhang, Baijun Dong, Yonghui Chen, Wen Kong, Qiang Liu, Wei Xue, Dongming Liu, Yiran Huang
Journal: Urologia Internationalis
Urol Int (2013) 90 (2): 174–178.
https://doi.org/10.1159/000342647
Published Online: 26 October 2012
View article titled, Primitive Neuroectodermal Tumor of the Kidney: A Single-Institute Series of Six Patients from China
Open the PDF for Primitive Neuroectodermal Tumor of the Kidney: A Single-Institute Series of Six Patients from China in another window
Journal Articles

Antifibrotic Role of Captopril after Ureteral Injury

Subject Area:
Further Areas
Jiahua Pan, Wei Xue, Qi Chen, Yonghui Chen, Haige Chen, Yiran Huang
Journal: Urologia Internationalis
Urol Int (2012) 89 (4): 418–424.
https://doi.org/10.1159/000341790
Published Online: 07 September 2012
View article titled, Antifibrotic Role of Captopril after Ureteral Injury
Open the PDF for Antifibrotic Role of Captopril after Ureteral Injury in another window
This Feature Is Available To Subscribers Only

or Create an Account

Close Modal
Close Modal